insulin degludec
insulin degludec is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including Insulin Degludec, Tresiba, TRESIBA. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin degludec
- Brand Names
- Insulin Degludec, Tresiba, TRESIBA
- Application Number
- BLA203314
- Sponsor
- Novo Nordisk Pharma, Inc.
- NDC Codes
- 11
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN DEGLUDEC
Indications and Usage
1 INDICATIONS AND USAGE TRESIBA is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use • Not recommended for the treatment of diabetic ketoacidosis. TRESIBA is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus ( 1 ). Limitations of Use: • Not recommended for the treatment of diabetic ketoacidosis.